Mimedx (MDXG) Amortizatization of Intangibles (2011 - 2026)
Mimedx recorded quarterly Amortizatization of Intangibles of $330000.0 in Q1 2026, up 1.54% quarter-over-quarter from $325000.0 in Q4 2025, and up 7.49% year-over-year from $307000.0 in Q1 2025.
Mimedx's Amortizatization of Intangibles history runs 16 years deep, the most recent figure standing at $330000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 7.49% year-over-year to $330000.0; the TTM figure through Mar 2026 stood at $1.3 million (up 25.12% YoY), while the FY2025 annual figure was $1.3 million, down 3.66% from the prior year.
- Amortizatization of Intangibles came in at $330000.0 for Q1 2026 at Mimedx, up from $325000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.2 million in Q4 2022 to a low of $22000.0 in Q1 2023.
- A 5-year average of $297117.6 and a median of $307000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles slumped 87.21% in 2023 and jumped 1340.91% in 2024, its largest moves.
- Mimedx's Amortizatization of Intangibles stood at $1.2 million in 2022, then plunged by 74.03% to $309000.0 in 2023, then rose by 9.39% to $338000.0 in 2024, then retreated by 3.85% to $325000.0 in 2025, then increased by 1.54% to $330000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $330000.0, $325000.0, and $318000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 330,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 330,000.00 |
| Mar 31, 2026 | 330,000.00 |
| Dec 31, 2025 | 325,000.00 |
| Dec 31, 2025 | 325,000.00 |
| Sep 30, 2025 | 318,000.00 |
| Sep 30, 2025 | 318,000.00 |
| Jun 30, 2025 | 312,000.00 |
| Jun 30, 2025 | 312,000.00 |
| Mar 31, 2025 | 307,000.00 |
| Mar 31, 2025 | 307,000.00 |
| Dec 31, 2024 | 338,000.00 |
| Dec 31, 2024 | 338,000.00 |
| Sep 30, 2024 | 192,000.00 |
| Sep 30, 2024 | 192,000.00 |
| Jun 30, 2024 | 190,000.00 |
| Jun 30, 2024 | 190,000.00 |
| Mar 31, 2024 | 317,000.00 |
| Mar 31, 2024 | 317,000.00 |
| Dec 31, 2023 | 309,000.00 |
| Dec 31, 2023 | 309,000.00 |
| Sep 30, 2023 | 190,000.00 |
| Sep 30, 2023 | 190,000.00 |
| Jun 30, 2023 | 191,000.00 |
| Jun 30, 2023 | 191,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 1.19 Mn |
| Dec 31, 2022 | 1.19 Mn |
| Sep 30, 2022 | 175,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 173,000.00 |
| Jun 30, 2022 | 173,000.00 |
| Mar 31, 2022 | 172,000.00 |
| Mar 31, 2022 | 172,000.00 |
| Dec 31, 2021 | 763,000.00 |
| Dec 31, 2021 | 763,000.00 |
| Sep 30, 2021 | 193,000.00 |
| Sep 30, 2021 | 193,000.00 |
| Jun 30, 2021 | 215,000.00 |
| Jun 30, 2021 | 215,000.00 |
| Mar 31, 2021 | 17,000.00 |
| Mar 31, 2021 | 17,000.00 |
| Dec 31, 2020 | 371,000.00 |
| Dec 31, 2020 | 371,000.00 |
| Sep 30, 2020 | 276,000.00 |
| Sep 30, 2020 | 276,000.00 |
| Jun 30, 2020 | 271,000.00 |
| Jun 30, 2020 | 271,000.00 |
| Mar 31, 2020 | 239,000.00 |
| Mar 31, 2020 | 239,000.00 |
| Dec 31, 2019 | 270,000.00 |
| Dec 31, 2019 | 270,000.00 |
| Sep 30, 2019 | 200,000.00 |
| Sep 30, 2019 | 200,000.00 |
| Jun 30, 2019 | 267,000.00 |
| Jun 30, 2019 | 267,000.00 |
| Mar 31, 2019 | 233,000.00 |
| Mar 31, 2019 | 233,000.00 |
| Sep 30, 2018 | 300,000.00 |
| Sep 30, 2018 | 300,000.00 |
| Jun 30, 2018 | 246,000.00 |
| Jun 30, 2018 | 246,000.00 |
| Mar 31, 2018 | 300,000.00 |
| Mar 31, 2018 | 300,000.00 |
| Dec 31, 2017 | 249,000.00 |
| Dec 31, 2017 | 249,000.00 |
| Sep 30, 2017 | 418,000.00 |
| Sep 30, 2017 | 418,000.00 |
| Jun 30, 2017 | 507,000.00 |
| Jun 30, 2017 | 507,000.00 |
| Mar 31, 2017 | 526,000.00 |
| Mar 31, 2017 | 526,000.00 |
| Dec 31, 2016 | 211,000.00 |
| Dec 31, 2016 | 211,000.00 |
| Sep 30, 2016 | 631,000.00 |
| Sep 30, 2016 | 631,000.00 |
| Jun 30, 2016 | 447,000.00 |
| Jun 30, 2016 | 447,000.00 |
| Mar 31, 2016 | 810,000.00 |
| Mar 31, 2016 | 810,000.00 |
| Dec 31, 2015 | 234,000.00 |
| Dec 31, 2015 | 234,000.00 |
| Sep 30, 2015 | 234,000.00 |
| Sep 30, 2015 | 234,000.00 |
| Jun 30, 2015 | 233,000.00 |
| Jun 30, 2015 | 233,000.00 |
| Mar 31, 2015 | 233,000.00 |
| Mar 31, 2015 | 233,000.00 |
| Dec 31, 2014 | 233,000.00 |
| Dec 31, 2014 | 233,000.00 |
| Sep 30, 2014 | 232,000.00 |
| Sep 30, 2014 | 232,000.00 |
| Jun 30, 2014 | 232,000.00 |
| Jun 30, 2014 | 232,000.00 |
| Mar 31, 2014 | 231,000.00 |
| Mar 31, 2014 | 231,000.00 |
| Dec 31, 2013 | 264,191.00 |
| Dec 31, 2013 | 264,191.00 |
| Sep 30, 2013 | 259,575.00 |
| Sep 30, 2013 | 259,575.00 |
| Jun 30, 2013 | 267,638.00 |
| Jun 30, 2013 | 267,638.00 |
| Mar 31, 2013 | 262,596.00 |
| Mar 31, 2013 | 262,596.00 |
| Dec 31, 2012 | 262,354.00 |
| Dec 31, 2012 | 262,354.00 |
| Sep 30, 2012 | 449,692.00 |
| Sep 30, 2012 | 449,692.00 |
| Jun 30, 2012 | 333,977.00 |
| Jun 30, 2012 | 333,977.00 |
| Mar 31, 2012 | 333,977.00 |
| Mar 31, 2012 | 333,977.00 |
| Dec 31, 2011 | 333,977.00 |
| Dec 31, 2011 | 333,977.00 |
| Sep 30, 2011 | 333,977.00 |
| Sep 30, 2011 | 333,977.00 |
| Jun 30, 2011 | 333,977.00 |
| Jun 30, 2011 | 333,977.00 |
| Mar 31, 2011 | 333,977.00 |
| Mar 31, 2011 | 333,977.00 |